Cantitate/Preț
Produs

Pharmaceutical Lifecycle Management – Making the Most of Each and Every Brand

Autor T Ellery
en Limba Engleză Hardback – 14 iun 2012
This book systematically explains how LCM strategies can help the pharmaceutical industry maximize the value of its patented brands through effective drug development programs and brand management. The authors share their combined 50 years of experience in the industry, citing numerous recent examples and case histories, and demonstrating how different measures can be combined to create winning strategies. The text helps pharmaceutical professionals understand challenges facing the industry and the role LCM has in confronting them, and offers a look ahead to predict which LCM strategies will continue to be effective in the future. A must-read for pharmaceutical executives and managers.
Citește tot Restrânge

Preț: 61399 lei

Preț vechi: 66738 lei
-8% Nou

Puncte Express: 921

Preț estimativ în valută:
11752 12222$ 9848£

Carte tipărită la comandă

Livrare economică 13-27 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780470487532
ISBN-10: 0470487534
Pagini: 412
Dimensiuni: 152 x 234 x 23 mm
Greutate: 0.73 kg
Editura: Wiley
Locul publicării:Hoboken, United States

Public țintă

Pharmaceutical executives and managers, including the following: Drug company CEO′s, Heads of Development and Marketing, Development Project Leaders and Project Teams, Brand Directors and Brand Teams

Formulations scientists, drug regulatory affairs managers, patent and IP professionals
Consultants, trainers, and contract research organizations (CROs)
 

Cuprins


Notă biografică

TONY ELLERY is a consultant with Ellery Pharma Consulting. Until September 2008, he was the Head of Pharmaceutical Lifecycle Management in Portfolio Management at Novartis AG. Prior to this, he occupied positions of increasing seniority in research, development, and marketing at different companies, including Roche, Ciba Vision, and Novartis. Dr. Ellery has served as a member of the Ciba-Geigy Research Advisory Board and the Novartis Pharma Development Management Board. He is a popular speaker on lifecycle, project, and portfolio management. NEAL HANSEN is the Managing Director of Healthcare Consulting within the Informa Group, encompassing Datamonitor Healthcare Consulting and Phasic Strategy. Previously, he was the European Head of Consulting within Wood Mackenzie's Life Sciences Practice. He works with many key players in the pharmaceutical industry to support effective decision making for brand and portfolio strategy and has chaired and spoken at numerous conferences in the field of lifecycle management and the changing nature of the generic drug industry.

Descriere

This book systematically explains how LCM strategies can help the pharmaceutical industry maximize the value of its patented brands through effective drug development programs and brand management.